1. Home
  2. RCMT vs TNYA Comparison

RCMT vs TNYA Comparison

Compare RCMT & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCM Technologies Inc.

RCMT

RCM Technologies Inc.

HOLD

Current Price

$29.40

Market Cap

198.3M

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.74

Market Cap

168.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RCMT
TNYA
Founded
1971
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
198.3M
168.2M
IPO Year
1997
2021

Fundamental Metrics

Financial Performance
Metric
RCMT
TNYA
Price
$29.40
$0.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$36.00
$5.33
AVG Volume (30 Days)
31.4K
2.0M
Earning Date
04-03-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
27.38
54.96
EPS
0.52
N/A
Revenue
$186,737,000.00
N/A
Revenue This Year
$11.89
N/A
Revenue Next Year
$12.46
N/A
P/E Ratio
$54.87
N/A
Revenue Growth
5.83
N/A
52 Week Low
$17.26
$0.53
52 Week High
$32.50
$2.35

Technical Indicators

Market Signals
Indicator
RCMT
TNYA
Relative Strength Index (RSI) 58.08 40.77
Support Level $27.02 $0.65
Resistance Level $29.38 $0.80
Average True Range (ATR) 0.78 0.05
MACD 0.02 -0.01
Stochastic Oscillator 60.12 0.00

Price Performance

Historical Comparison
RCMT
TNYA

About RCMT RCM Technologies Inc.

RCM Technologies Inc is a provider of business and technology solutions designed to enhance and maximize the operational performance of its customers. It operates in three segments: Specialty Health Care, Engineering, and Life Sciences, Data and Solutions (LS&D). The company generates maximum revenue from the Specialty Health Care segment that provides staffing solutions, including medical healthcare professionals, health information management professionals, nurses, paraprofessionals, physicians, and therapists. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Puerto Rico, and Europe.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: